(Q39007220)

8 September 2017

microRNA-218 increase the sensitivity of gastrointestinal stromal tumor to imatinib through PI3K/AKT pathway (English)

1 reference

gastrointestinal stromal tumor

8 September 2017

1 reference

1 reference

1 reference

Rong Fan

1

1 reference

8 September 2017

Jie Zhong

2

1 reference

8 September 2017

Sichang Zheng

3

1 reference

8 September 2017

Zhengting Wang

4

1 reference

8 September 2017

Ying Xu

5

1 reference

8 September 2017

Shuyi Li

6

1 reference

8 September 2017

Jie Zhou

7

1 reference

8 September 2017

Fei Yuan

8

1 reference

8 September 2017

5 April 2014

1 reference

Clinical and Experimental Medicine

8 September 2017

1 reference

8 September 2017

15

1 reference

8 September 2017

2

1 reference

8 September 2017

137-144

1 reference

https://scigraph.springernature.com/pub.10.1007/s10238-014-0280-y

8 September 2017

0 references

cites work

High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Gastrointestinal stromal tumor--background, pathology, treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Gastrointestinal stromal tumors: risk assessment and adjuvant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Adherence to imatinib therapy in patients with gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Briefing in family characteristics of microRNAs and their applications in cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

MicroRNAs in the axon and presynaptic nerve terminal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

miR-128 and its target genes in tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Pivotal role of microRNAs in cardiac physiology and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

New fronts in the adjuvant treatment of GIST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Navigating the therapeutic complexity of PI3K pathway inhibition in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Diets involved in PPAR and PI3K/AKT/PTEN pathway may contribute to neuroprotection in a traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3'-kinase is essential for male fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Kit/stem cell factor receptor-induced phosphatidylinositol 3'-kinase signalling is not required for normal development and function of interstitial cells of Cajal in mouse gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Management of gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

A potent combination of the novel PI3K Inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts: long-lasting responses after treatment withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-014-0280-Y

Gastrointestinal stromal tumor

21 January 2018

1 reference

12 December 2020

Surgical treatment of esophageal leiomyoma larger than 5 cm in diameter: A case report and review of the literature

1 reference

12 December 2020

Functional role of microvesicles in gastrointestinal malignancies

1 reference

12 December 2020

Inpatient burden of gastrointestinal stromal tumors in the United States

1 reference

12 December 2020

From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).

1 reference

12 December 2020

miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9.

1 reference

12 December 2020

Update on imatinib for gastrointestinal stromal tumors: duration of treatment

1 reference

12 December 2020

Targeted therapy in soft tissue sarcoma-a novel direction in therapeutics

1 reference

12 December 2020

Massive intra-abdominal imatinib-resistant gastrointestinal stromal tumor in a 21-year-old male

1 reference

12 December 2020

Criminal or bystander: imatinib and second primary malignancy in GIST patients

1 reference

12 December 2020

Neoodjuvant imatinib mesylate for advanced primary and metastactic/recurrent gastro-intestinal stromal tumour (GIST).

1 reference

12 December 2020

Effectiveness of radiation therapy in GIST: A case report

1 reference

12 December 2020

Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings

1 reference

12 December 2020

Screening of differentially expressed microRNAs in borderline and malignant gastrointestinal stromal tumors

1 reference

12 December 2020

10.1007/S10238-014-0280-Y

Identifiers

DOI

1 reference

8 September 2017

1 reference